Massimiliano Galdiero Selected Research

Fingolimod Hydrochloride (FTY720)

12/2022	Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod.
4/2022	Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Massimiliano Galdiero Research Topics

Disease

32	Infections 04/2024 - 09/2003
15	COVID-19 10/2023 - 12/2020
12	Virus Diseases (Viral Diseases) 04/2024 - 03/2008
7	Neoplasms (Cancer) 11/2023 - 03/2014
6	Bacterial Infections (Bacterial Infection) 04/2024 - 04/2006
5	Communicable Diseases (Infectious Diseases) 03/2024 - 01/2015
5	Multiple Sclerosis 12/2022 - 01/2021
4	Herpes Simplex 10/2022 - 12/2011
3	Sepsis (Septicemia) 01/2024 - 01/2023
3	Eye Infections 08/2022 - 07/2021
2	Necrosis 09/2022 - 08/2022
2	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 01/2015
2	Thrombosis (Thrombus) 03/2021 - 01/2021
2	ST Elevation Myocardial Infarction 03/2021 - 01/2021
2	Carcinogenesis 01/2019 - 01/2016
2	Liver Neoplasms (Liver Cancer) 10/2018 - 08/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2012 - 08/2010
1	Thrombocytopenia (Thrombopenia) 01/2024
1	Urinary Tract Infections (Urinary Tract Infection) 01/2024
1	Pneumonia (Pneumonitis) 01/2024
1	Morbillivirus Infections 12/2023
1	Measles 12/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2023
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2023
1	Hematologic Neoplasms (Hematological Malignancy) 10/2023
1	Hemolysis 10/2023
1	Escherichia coli Infections 10/2023
1	Staphylococcal Infections 09/2023
1	Wounds and Injuries (Trauma) 07/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	HIV Infections (HIV Infection) 01/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023
1	Septic Shock (Toxic Shock Syndrome) 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Common Variable Immunodeficiency 01/2023
1	Keratitis 08/2022

Drug/Important Bio-Agent (IBA)

17	Antiviral Agents (Antivirals)IBA 03/2024 - 10/2011
16	Peptides (Polypeptides)IBA 03/2024 - 05/2006
12	VaccinesIBA 01/2024 - 02/2012
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 04/2012
6	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2015
6	Glycoproteins (Glycoprotein)IBA 01/2021 - 05/2006
5	COVID-19 VaccinesIBA 01/2023 - 09/2021
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2014
4	CytokinesIBA 01/2015 - 02/2004
3	Interleukin-6 (Interleukin 6)IBA 03/2023 - 09/2014
3	Interleukin-8 (Interleukin 8)IBA 03/2023 - 09/2014
3	AntibodiesIBA 01/2023 - 01/2021
3	BNT162 VaccineIBA 01/2023 - 05/2022
3	Messenger RNA (mRNA)IBA 12/2022 - 04/2022
3	ocrelizumabIBA 12/2022 - 09/2021
3	mRNA VaccinesIBA 05/2022 - 01/2021
2	Dendrimers (Dendrons)IBA 12/2023 - 03/2021
2	nitazoxanide (NTZ)FDA Link 12/2023 - 05/2022
2	Neutralizing AntibodiesIBA 10/2023 - 03/2022
2	Antimicrobial PeptidesIBA 09/2023 - 01/2015
2	InterleukinsIBA 03/2023 - 09/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 03/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 12/2020
2	Fingolimod Hydrochloride (FTY720)FDA Link 12/2022 - 04/2022
2	Ophthalmic Solutions (Eye Drops)IBA 08/2022 - 07/2021
2	Natalizumab (Tysabri)FDA Link 05/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
2	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2016
2	Estrogens (Estrogen)FDA Link 01/2019 - 01/2015
2	Liposomes (Liposome)IBA 01/2016 - 07/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 07/2015
2	SilverIBA 05/2015 - 03/2014
2	Anti-Infective Agents (Microbicides)IBA 03/2014 - 04/2013
1	ElementsIBA 04/2024
1	Gallic AcidIBA 04/2024
1	punicalinIBA 04/2024
1	Ellagic AcidIBA 04/2024
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2024
1	LactamsIBA 01/2024
1	Oncogene Proteins (Oncogene Protein)IBA 11/2023
1	Monoclonal AntibodiesIBA 10/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 10/2023
1	thiazolyl blueIBA 10/2023
1	cupferronIBA 10/2023
1	Melitten (Melittin)IBA 09/2023
1	GlycosaminoglycansIBA 09/2023
1	selamectinIBA 09/2023
1	ceftazidime drug combination avibactamIBA 02/2023
1	tazobactam drug combination ceftolozaneIBA 02/2023
1	beta-LactamsIBA 02/2023
1	CefiderocolIBA 02/2023
1	LipidsIBA 01/2023
1	n-hexaneIBA 10/2022
1	ethyl acetateIBA 10/2022
1	Arctostaphylos uva-ursi leafIBA 09/2022
1	Retinaldehyde (Retinal)IBA 08/2022
1	rheinIBA 08/2022

Therapy/Procedure

10	Therapeutics 04/2024 - 10/2011
2	Percutaneous Coronary Intervention 03/2021 - 01/2021
2	Microbubbles 10/2018 - 08/2018
1	Catheters 07/2023
1	Art Therapy 01/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Length of Stay 01/2023